• 1
    World Health Organization. The ICD-10 classification of mental and behavioural disorders. Diagnostic criteria for research. Geneva: WHO, 1993.
  • 2
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn, Text Revision. Washington, DC: American Psychiatric Association, 2000.
  • 3
    Ostergaard SD, Rothschild AJ, Uggerby P, Munk-Jorgensen P, Bech P, Mors O. Considerations on the ICD-11 classification of psychotic depression. Psychother Psychosom 2012;81:135144.
  • 4
    Rothschild AJ. Clinical manual for diagnosis and treatment of psychotic depression. Washington DC, USA: American Psychiatric Publishing, Inc., 2009.
  • 5
    Ostergaard SD, Petrides G, Dinesen PT et al. The Association between physical morbidity and subtypes of severe depression. Psychother Psychosom 2013;82:4552.
  • 6
    Ostergaard SD, Waltoft BL, Mortensen PB, Mors O. Environmental and familial risk factors for psychotic and non-psychotic severe depression. J Affect Disord 2013;147:232240.
  • 7
    Domschke K, Lawford B, Young R et al. Dysbindin (DTNBP1) – a role in psychotic depression? J Psychiatr Res 2010;45:588595.
  • 8
    Nelson JC, Davis JM. DST studies in psychotic depression: a meta-analysis. Am J Psychiatry 1997;154:14971503.
  • 9
    Posener JA, Debattista C, Williams GH, Chmura Kraemer H, Kalehzan BM, Schatzberg AF. 24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. Arch Gen Psychiatry 2000;57:755760.
  • 10
    Cubells JF, Price LH, Meyers BS et al. Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression. Biol Psychiatry 2002;51:358364.
  • 11
    Meyers BS, Alexopoulos GS, Kakuma T et al. Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression. Biol Psychiatry 1999;45:448452.
  • 12
    Maj M, Pirozzi R, Magliano L, Fiorillo A, Bartoli L. Phenomenology and prognostic significance of delusions in major depressive disorder: a 10-year prospective follow-up study. J Clin Psychiatry 2007;68:14111417.
  • 13
    Ostergaard SD, Bille J, Soltoft-Jensen H, Lauge N, Bech P. The validity of the severity-psychosis hypothesis in depression. J Affect Disord 2012;140:4856.
  • 14
    Coryell W, Leon A, Winokur G et al. Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry 1996;153:483489.
  • 15
    Rothschild AJ, Samson JA, Bond TC, Luciana MM, Schildkraut JJ, Schatzberg AF. Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression. Biol Psychiatry 1993;34:392400.
  • 16
    Johnson J, Horwath E, Weissman MM. The validity of major depression with psychotic features based on a community study. Arch Gen Psychiatry 1991;48:10751081.
  • 17
    Vythilingam M, Chen J, Bremner JD, Mazure CM, Maciejewski PK, Nelson JC. Psychotic depression and mortality. Am J Psychiatry 2003;160:574576.
  • 18
    Park MH, Kim TS, Yim HW et al. Clinical characteristics of depressed patients with a history of suicide attempts: results from the CRESCEND study in South Korea. J Nerv Ment Dis 2010;198:748754.
  • 19
    Ostergaard SD, Bertelsen A, Nielsen J, Mors O, Petrides G. The association between psychotic mania, psychotic depression and mixed affective episodes among 14,529 patients with bipolar disorder. J Affect Disord 2013;147:4450.
  • 20
    Spiker DG, Kupfer DJ. Placebo response rates in psychotic and nonpsychotic depression. J Affect Disord 1988;14:2123.
  • 21
    Glassman AH, Roose SP. Delusional depression. A distinct clinical entity? Arch Gen Psychiatry 1981;38:424427.
  • 22
    Charney DS, Nelson JC. Delusional and nondelusional unipolar depression: further evidence for distinct subtypes. Am J Psychiatry 1981;138:328333.
  • 23
    Schatzberg AF, Rothschild AJ. Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? Am J Psychiatry 1992;149:733745.
  • 24
    Nelson WH, Khan A, Orr WW Jr. Delusional depression. Phenomenology, neuroendocrine function, and tricyclic antidepressant response. J Affect Disord 1984;6:297306.
  • 25
    Spiker DG, Weiss JC, Dealy RS et al. The pharmacological treatment of delusional depression. Am J Psychiatry 1985;142:430436.
  • 26
    Brown RP, Frances A, Kocsis JH, Mann JJ. Psychotic vs. nonpsychotic depression: comparison of treatment response. J Nerv Ment Dis 1982;170:635637.
  • 27
    Chan CH, Janicak PG, Davis JM, Altman E, Andriukaitis S, Hedeker D. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. J Clin Psychiatry 1987;48:197200.
  • 28
    Petrides G, Fink M, Husain MM et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 2001;17:244253.
  • 29
    Loo CK, Mahon M, Katalinic N, Lyndon B, Hadzi-Pavlovic D. Predictors of response to ultrabrief right unilateral electroconvulsive therapy. J Affect Disord 2011;130:1927.
  • 30
    Birkenhager TK, Pluijms EM, Lucius SA. ECT response in delusional versus non-delusional depressed inpatients. J Affect Disord 2003;74:191195.
  • 31
    Meyers BS, Flint AJ, Rothschild AJ et al. A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Arch Gen Psychiatry 2009;66:838847.
  • 32
    Wijkstra J, Burger H, van den Broek WW et al. Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine. Acta Psychiatr Scand 2010;121:190200.
  • 33
    Rothschild AJ, Williamson DJ, Tohen MF et al. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. J Clin Psychopharmacol 2004;24:365373.
  • 34
    Farahani A, Correll CU. Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment. J Clin Psychiatry 2012;73:486496.
  • 35
    Leadholm AK, Rothschild AJ, Nolen WA, Bech P, Munk-Jorgensen P, Ostergaard SD. The treatment of psychotic depression: is there consensus among guidelines and psychiatrists? J Affect Disord 2013;145:214220.
  • 36
    Feinstein AR. T. Duckett Jones Memorial Lecture. The Jones criteria and the challenges of clinimetrics. Circulation 1982;66:15.
  • 37
    Fava GA, Tomba E, Sonino N. Clinimetrics: the science of clinical measurements. Int J Clin Pract 2012;66:1115.
  • 38
    Bech P. Clinical psychometrics. Oxford, UK: Wiley-Blackwell, 2012.
  • 39
    Stochl J, Jones PB, Croudace TJ. Mokken scale analysis of mental health and well-being questionnaire item responses: a non-parametric IRT method in empirical research for applied health researchers. BMC Med Res Methodol 2012;. doi:10.1186/1471-2288-12-74.
  • 40
    Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278296.
  • 41
    Bech P. Pharmacological treatment of depressive disorders: a review. In: Maj M, Sartorius N, eds. Depressive disorders. WPA series evidence and experience in psychiatry. Chichester: John Wiley & Sons, 1999.
  • 42
    Bech P, Gram LF, Dein E, Jacobsen O, Vitger J, Bolwig TG. Quantitative rating of depressive states. Acta Psychiatr Scand 1975;51:161170.
  • 43
    Bech P, Allerup P, Gram LF et al. The Hamilton depression scale. Evaluation of objectivity using logistic models. Acta Psychiatr Scand 1981;63:290299.
  • 44
    Licht RW, Qvitzau S, Allerup P, Bech P. Validation of the Bech-Rafaelsen Melancholia Scale and the Hamilton Depression Scale in patients with major depression; is the total score a valid measure of illness severity? Acta Psychiatr Scand 2005;111:144149.
  • 45
    Bech P, Fava M, Trivedi MH, Wisniewski SR, Rush AJ. Factor structure and dimensionality of the two depression scales in STAR*D using level 1 datasets. J Affect Disord 2011;132:396400.
  • 46
    Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987;334:1100.
  • 47
    Bech P. Is the antidepressive effect of second-generation antidepressants a myth? Psychol Med 2010;40:181186.
  • 48
    Bech P. The three-fold Hamilton Depression Scale: an editorial comment to Isacsson G, Adler M. Randomized clinical trials underestimate the efficacy of antidepressants in less severe depression (1). Acta Psychiatr Scand 2012;125:423424.
  • 49
    Bech P, Boyer P, Germain JM et al. HAM-D17 and HAM-D6 sensitivity to change in relation to desvenlafaxine dose and baseline depression severity in major depressive disorder. Pharmacopsychiatry 2010;43:271276.
  • 50
    Bech P, Fava M, Trivedi MH, Wisniewski SR, Rush AJ. Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial. Acta Psychiatr Scand 2012;125:342348.
  • 51
    Bech P, Allerup P, Larsen ER, Csillag C, Licht R. Escitalopram versus nortriptyline: how to let the clinical GENDEP data tell us what they contained. Acta Psychiatr Scand 2013;127:328329.
  • 52
    Wijkstra J, Lijmer J, Balk FJ, Geddes JR, Nolen WA. Pharmacological treatment for unipolar psychotic depression: systematic review and meta-analysis. Br J Psychiatry 2006;188:410415.
  • 53
    Preti A, Bonventre E, Ledda V, Petretto DR, Masala C. Hallucinatory experiences, delusional thought proneness, and psychological distress in a nonclinical population. J Nerv Ment Dis 2007;195:484491.
  • 54
    Langer AI, Cangas AJ, Serper M. Analysis of the multidimensionality of hallucination-like experiences in clinical and nonclinical Spanish samples and their relation to clinical symptoms: implications for the model of continuity. Int J Psychol 2011;46:4654.
  • 55
    Johns LC. Hallucinations in the general population. Curr Psychiatry Rep 2005;7:162167.
  • 56
    Johns LC, van Os J. The continuity of psychotic experiences in the general population. Clin Psychol Rev 2001;21:11251141.
  • 57
    Meyers BS, English J, Gabriele M et al. A delusion assessment scale for psychotic major depression: reliability, validity, and utility. Biol Psychiatry 2006;60:13361342.
  • 58
    Williams JB, Kobak KA, Bech P et al. The GRID-HAMD: standardization of the Hamilton depression rating scale. Int Clin Psychopharmacol 2008;23:120129.
  • 59
    Spitzer R, Endicott J. Schedule for affective disorders and schizophrenia, 3rd edn. New York: Biometrics Research Dept, New York State Psychiatric Institute, 1979.
  • 60
    Guy W eds. Clinical global impressions scale. In: ECDEU assessment manual for psychopharmacology. Rockville, MD, USA: US Department of Health, Education and Welfare pub no (AMD) 76-338, NIMH, 1976.
  • 61
    Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep 1962;10:799812.
  • 62
    Hotelling H. Rotations in psychology and the statistical revolution. Science 1942;95:504507.
  • 63
    Hotelling H. Analysis of a complex of statistical variables with principal components. J Educ Psychol 1933;24:417441.
  • 64
    Mokken RJ. Theory and practice of scale analysis. Berlin, Germany: Mouton, 1971.
  • 65
    Loevinger J. Objective tests as instruments of psychological theory. Biol Psychiatry 1957;3:635694.
  • 66
    Molenaar IW, Debels P, Sijtsna K. User's manual MSP, a program for Mokken Scale analyses for Polytomous Items (version 3.0). Groeningen, The Netherlands: ProGAMMA, 1994.
  • 67
    Wijkstra J, Lijmer J, Balk F, Geddes J, Nolen WA. Pharmacological treatment for psychotic depression. Cochrane Database Syst Rev 2005;4:CD004044.